These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23519525)

  • 1. Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy.
    Ishii S; Inomata T; Ikeda Y; Nabeta T; Iwamoto M; Watanabe I; Naruke T; Shinagawa H; Koitabashi T; Nishii M; Takeuchi I; Izumi T
    Heart Vessels; 2014 Jan; 29(1):88-96. PubMed ID: 23519525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Iida Y; Iwamoto-Ishida M; Nabeta T; Ishii S; Sato T; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Nishii M; Ako J
    Heart Vessels; 2016 Apr; 31(4):545-54. PubMed ID: 25686768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy.
    Ishii S; Inomata T; Fujita T; Iida Y; Ikeda Y; Nabeta T; Yanagisawa T; Naruke T; Mizutani T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Dec; 31(12):1960-1968. PubMed ID: 26920939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of global circumferential strain as prognostic marker after administration of β-blockers for dilated cardiomyopathy.
    Tanaka H; Matsumoto K; Sawa T; Miyoshi T; Motoji Y; Imanishi J; Mochizuki Y; Tatsumi K; Hirata K
    Int J Cardiovasc Imaging; 2014 Oct; 30(7):1279-87. PubMed ID: 24899221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
    Puntmann VO; Carr-White G; Jabbour A; Yu CY; Gebker R; Kelle S; Hinojar R; Doltra A; Varma N; Child N; Rogers T; Suna G; Arroyo Ucar E; Goodman B; Khan S; Dabir D; Herrmann E; Zeiher AM; Nagel E;
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):40-50. PubMed ID: 26762873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral endothelial function may predict the effectiveness of beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Xie X; Wu B; Chen Y; Li W; Hu X; Chen J
    Int J Cardiol; 2016 Oct; 221():128-33. PubMed ID: 27400309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of baseline heart rate as a predictor of cardiac functional recovery in newly diagnosed heart failure with reduced ejection fraction.
    Valika A; Paprockas K; Villines D; Costanzo MR
    Clin Cardiol; 2018 Jun; 41(6):752-757. PubMed ID: 29512170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
    Bonnet D; Berger F; Jokinen E; Kantor PF; Daubeney PEF
    J Am Coll Cardiol; 2017 Sep; 70(10):1262-1272. PubMed ID: 28859790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T; Naya M; Manabe O; Wakasa S; Kubota S; Chiba S; Iwano H; Yamada S; Yoshinaga K; Tamaki N; Tsutsui H; Matsui Y
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):762-70. PubMed ID: 21757167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial Tissue Reverse Remodeling After Guideline-Directed Medical Therapy in Idiopathic Dilated Cardiomyopathy.
    Xu Y; Li W; Wan K; Liang Y; Jiang X; Wang J; Mui D; Li Y; Tang S; Guo J; Guo X; Liu X; Sun J; Zhang Q; Han Y; Chen Y
    Circ Heart Fail; 2021 Jan; 14(1):e007944. PubMed ID: 33185117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-Blocker Use Is Associated With Prevention of Left Ventricular Remodeling in Recovered Dilated Cardiomyopathy.
    Enzan N; Matsushima S; Ide T; Kaku H; Tohyama T; Funakoshi K; Higo T; Tsutsui H
    J Am Heart Assoc; 2021 Jun; 10(12):e019240. PubMed ID: 34053244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy.
    Choi JO; Kim EY; Lee GY; Lee SC; Park SW; Kim DK; Oh JK; Jeon ES
    Circ J; 2013; 77(2):462-9. PubMed ID: 23095684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure　- J-SHIFT Study.
    Tsutsui H; Momomura SI; Yamashina A; Shimokawa H; Kihara Y; Saito Y; Hagiwara N; Ito H; Yano M; Yamamoto K; Ako J; Inomata T; Sakata Y; Tanaka T; Kawasaki Y;
    Circ J; 2019 Sep; 83(10):2049-2060. PubMed ID: 31391387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac fibrosis detected by magnetic resonance imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Fujita T; Iida Y; Nabeta T; Ishii S; Maekawa E; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Nov; 31(11):1817-1825. PubMed ID: 26843195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
    Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.